{
    "organizations": [],
    "uuid": "9bbc38421065cd5e0dc220b80b9ffc6b8b127acd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neovacs-granted-a-new-patent-from/brief-neovacs-granted-a-new-patent-from-russian-federation-patent-office-idUSFWN1PB00W",
    "ord_in_thread": 0,
    "title": "BRIEF-Neovacs ‍Granted A New Patent From Russian Federation Patent Office (Rospatent)​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - NEOVACS SA:\n* ‍GRANTED A NEW PATENT FROM RUSSIAN FEDERATION PATENT OFFICE (ROSPATENT)​\n* ‍PATENT STRENGTHENS NEOVACS’ INTERFERON ALPHA (IFNALPHA)-RELATED INTELLECTUAL PROPERTY PORTFOLIO​\n* ‍PATENT UNTIL AT LEAST 2032 ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-16T14:05:00.000+02:00",
    "crawled": "2018-01-17T19:49:03.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "neovacs",
        "sa",
        "new",
        "patent",
        "russian",
        "federation",
        "patent",
        "office",
        "rospatent",
        "strengthens",
        "neovacs",
        "interferon",
        "alpha",
        "ifnalpha",
        "intellectual",
        "property",
        "least",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}